DENVER, July 29, 2011 (GLOBE NEWSWIRE) -- Air Methods Corporation (Nasdaq:AIRM), the largest air medical transportation company in the world, announced today that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) for its proposed transaction to acquire OF Air Holdings Corporation and its subsidiaries, including Omniflight Helicopters, Inc. (together, Omniflight).
Completion of the transaction between Air Methods and Omniflight is subject to customary closing conditions. The parties currently expect to complete the transaction on or around August 1, 2011.
Air Methods Corporation (www.airmethods.com) is a leader in emergency aeromedical transportation and medical services. The Hospital Based Services Division is the largest provider of air medical transport services for hospitals. The Community Based Services Division is one of the largest community-based providers of air medical services. The Products Division specializes in the design and manufacture of aeromedical and aerospace technology. The Company's fleet of owned, leased or maintained aircraft features over 300 helicopters and fixed wing aircraft.
The Air Methods Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6955
Forward Looking Statements: This press release contains forward-looking statements which are subject to safe harbors created under the U.S. federal securities laws, including, but not limited to, statements relating to the proposed transaction between Air Methods and Omniflight and the expected timing and completion of the transaction. Such statements are based upon the current beliefs and expectations of Air Methods' management and involve a number of significant risks and uncertainties, many of which are difficult to predict and are generally beyond the control of Air Methods and Omniflight. Actual results may differ materially from the results anticipated in these forward-looking statements. There can be no assurance as to the timing of the closing of the transaction, or whether the transaction will close at all. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. For information regarding other related risks, see the "Risk Factors" section of the Company's most recent Form 10-K filed with the SEC on March 11, 2011, and other risk factors described from time to time in the Company's 10-Q and 10-K filings with the SEC.
Please contact Christine Clarke at (303) 792-7579 to be included on the Company's fax and/or mailing list.